TY - JOUR
T1 - Atomic resolution structures of discrete stages on the reaction coordinate of the [Fe4S4] enzyme IspG (GcpE)
AU - Quitterer, Felix
AU - Frank, Annika
AU - Wang, Ke
AU - Rao, Guodong
AU - O'Dowd, Bing
AU - Li, Jikun
AU - Guerra, Francisco
AU - Abdel-Azeim, Safwat
AU - Bacher, Adelbert
AU - Eppinger, Jörg
AU - Oldfield, Eric
AU - Groll, Michael
N1 - KAUST Repository Item: Exported on 2020-10-01
PY - 2015/4/11
Y1 - 2015/4/11
N2 - IspG is the penultimate enzyme in non-mevalonate biosynthesis of the universal terpene building blocks isopentenyl diphosphate and dimethylallyl diphosphate. Its mechanism of action has been the subject of numerous studies but remained unresolved due to difficulties in identifying distinct reaction intermediates. Using a moderate reducing agent as well as an epoxide substrate analogue, we were now able to trap and crystallographically characterize various stages in the IspG catalyzed conversion of 2-C-methyl-D-erythritol-2,4-cyclo-diphosphate (MEcPP) to (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate (HMBPP). In addition, the enzyme’s structure was determined in complex with several inhibitors. These results, combined with recent electron paramagnetic resonance data, allowed us to deduce a detailed and complete IspG catalytic mechanism which describes all stages from initial ring opening to formation of HMBPP via discrete radical and carbanion intermediates. The data presented in this article provide a guide for the design of selective drugs against many pro- and eukaryotic pathogens to which the non-mevalonate pathway is essential for survival and virulence.
AB - IspG is the penultimate enzyme in non-mevalonate biosynthesis of the universal terpene building blocks isopentenyl diphosphate and dimethylallyl diphosphate. Its mechanism of action has been the subject of numerous studies but remained unresolved due to difficulties in identifying distinct reaction intermediates. Using a moderate reducing agent as well as an epoxide substrate analogue, we were now able to trap and crystallographically characterize various stages in the IspG catalyzed conversion of 2-C-methyl-D-erythritol-2,4-cyclo-diphosphate (MEcPP) to (E)-1-hydroxy-2-methylbut-2-enyl-4-diphosphate (HMBPP). In addition, the enzyme’s structure was determined in complex with several inhibitors. These results, combined with recent electron paramagnetic resonance data, allowed us to deduce a detailed and complete IspG catalytic mechanism which describes all stages from initial ring opening to formation of HMBPP via discrete radical and carbanion intermediates. The data presented in this article provide a guide for the design of selective drugs against many pro- and eukaryotic pathogens to which the non-mevalonate pathway is essential for survival and virulence.
UR - http://hdl.handle.net/10754/550086
UR - http://linkinghub.elsevier.com/retrieve/pii/S0022283615002259
UR - http://www.scopus.com/inward/record.url?scp=84937764562&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2015.04.002
DO - 10.1016/j.jmb.2015.04.002
M3 - Article
C2 - 25868383
SN - 0022-2836
VL - 427
SP - 2220
EP - 2228
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 12
ER -